1. Clinical Overview
Metadoxine is a pyridoxine-pyrrolidone carboxylate complex, primarily indicated for the management of acute alcohol intoxication and chronic alcoholism. It acts as an alcohol dehydrogenase (ADH) activator and aldehyde dehydrogenase (ALDH) inhibitor, accelerating ethanol metabolism and reducing acetaldehyde accumulation. It also exhibits hepatoprotective and antioxidant properties, making it useful in alcoholic liver disease. In the Indian context, it is widely prescribed for alcohol-related disorders and as an adjuvant in fatty liver disease.
| Onset | Duration | Bioavailability |
|---|---|---|
| Within 1-2 hours after oral administration. | Approximately 6-8 hours. | Approximately 60-70% after oral administration. |
2. Mechanism of Action
Metadoxine exerts its primary effect by modulating the enzymes involved in ethanol metabolism. It increases the activity of alcohol dehydrogenase (ADH), accelerating the conversion of ethanol to acetaldehyde. Simultaneously, it inhibits aldehyde dehydrogenase (ALDH), slowing the conversion of acetaldehyde to acetate. This 'accelerated displacement' helps clear ethanol from the blood more rapidly while the transiently elevated acetaldehyde may contribute to an aversive effect. It also exhibits direct hepatoprotective effects by reducing fatty infiltration, inhibiting collagen deposition, and acting as an antioxidant and free radical scavenger.
3. Indications & Uses
- Acute Alcohol Intoxication
- Chronic Alcoholism (as an adjuvant therapy)
- Alcoholic Fatty Liver Disease (AFLD)
4. Dosage & Administration
Adult Dosage: 500mg to 1000mg (1-2 tablets of 500mg) orally, twice daily. For acute intoxication: 1000mg (2 tablets) as a single dose, may be repeated once after 6-8 hours if needed.
Administration: Tablet should be swallowed whole with a full glass of water, with or without food. For best results in chronic use, take at consistent times daily. Do not crush or chew.
5. Side Effects
Common side effects may include:
- Nausea
- Headache
- Dizziness
- Gastric irritation / Heartburn
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Levodopa | Pyridoxine can decrease the efficacy of levodopa by enhancing its peripheral decarboxylation. Metadoxine may reduce levodopa's antiparkinsonian effect. | Major |
| Phenobarbital / Phenytoin | Pyridoxine may decrease serum levels of these antiepileptics, potentially reducing seizure control. | Moderate |
| Isoniazid (INH) | Isoniazid is a pyridoxine antagonist. Concomitant use may increase the requirement for pyridoxine, potentially reducing Metadoxine's efficacy for its primary indication. | Moderate |
| Disulfiram | Both drugs affect aldehyde metabolism. Concomitant use may lead to exaggerated acetaldehyde syndrome (flushing, tachycardia, nausea). Use with extreme caution. | Major |
| CNS Depressants (Benzodiazepines, Opioids) | Additive sedative effect, especially when used for acute intoxication. | Moderate |
7. Patient Counselling
- DO take the medicine exactly as prescribed by your doctor.
- DO inform your doctor if you are taking any other medicines, especially for Parkinson's or seizures.
- DO combine this medication with lifestyle changes like a balanced diet and reduced/stopped alcohol intake for liver conditions.
- DONT consume alcohol while on this medication for chronic alcoholism or fatty liver, as it defeats the purpose.
- DONT drive or operate heavy machinery if you feel dizzy or drowsy after taking the medicine.
- DONT take a double dose to make up for a missed one.
8. Toxicology & Storage
Overdose: Symptoms of overdose are primarily related to the pyridoxine component and may include: severe sensory neuropathy (numbness, ataxia), photosensitivity, nausea, vomiting, headache, and in extreme cases, seizures.
Storage: Store at room temperature (15-30°C), protected from light and moisture. Keep the container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack.